PEAK6’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105K Hold
200
– – ﹤0.01% 2405
2026
Q1
$112K Sell
200
-1,600
-89% -$1.03M ﹤0.01% 2368
2025
Q4
$1.22M Buy
1,800
+600
+50% +$409K ﹤0.01% 1679
2025
Q3
$767K Sell
1,200
-700
-37% -$425K ﹤0.01% 1963
2025
Q2
$1.02M Buy
1,900
+700
+58% +$335K ﹤0.01% 1798
2025
Q1
$504K Buy
+1,200
New +$521K ﹤0.01% 2080

Other funds holding IDXX

PEAK6's IDXX Position: Q2 2026 in Review

PEAK6 reduced its Idexx Laboratories (IDXX) stake by 99% in Q2 2026, selling an estimated $2.03M and leaving 28 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2540.

PEAK6 first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.05M in Q1 2026. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • PEAK6 held 28 shares of Idexx Laboratories worth $14.7K as of Q2 2026.
  • PEAK6 sold 3,612 Idexx Laboratories shares in Q2 2026, an estimated $2.03M.
  • Idexx Laboratories made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2540 holding.
  • PEAK6 first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • PEAK6's Idexx Laboratories position peaked at $2.05M in Q1 2026.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.